These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 1421692)
1. E-cadherin expression: a counterbalance for cancer cell invasion. Mareel M; Vleminckx K; Vermeulen S; Bracke M; Van Roy F Bull Cancer; 1992; 79(4):347-55. PubMed ID: 1421692 [TBL] [Abstract][Full Text] [Related]
2. Downregulation in vivo of the invasion-suppressor molecule E-cadherin in experimental and clinical cancer. Mareel M; Vleminckx K; Vermeulen S; Yan G; Bracke M; van Roy F Princess Takamatsu Symp; 1994; 24():63-80. PubMed ID: 8983064 [TBL] [Abstract][Full Text] [Related]
3. Decreased expression of E-cadherin in the progression of rat prostatic cancer. Bussemakers MJ; van Moorselaar RJ; Giroldi LA; Ichikawa T; Isaacs JT; Takeichi M; Debruyne FM; Schalken JA Cancer Res; 1992 May; 52(10):2916-22. PubMed ID: 1581909 [TBL] [Abstract][Full Text] [Related]
4. Cancer metastasis: negative regulation by an invasion-suppressor complex. Mareel M; Bracke M; Van Roy F Cancer Detect Prev; 1995; 19(5):451-64. PubMed ID: 7585733 [TBL] [Abstract][Full Text] [Related]
5. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180 [TBL] [Abstract][Full Text] [Related]
6. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602 [TBL] [Abstract][Full Text] [Related]
7. Alterations of the cadherin-catenin cell adhesion system in cancers. Kanai Y; Oda T; Shimoyama Y; Ochiai A; Oyama T; Yoshiura K; Akimoto S; Yamada T; Hirohashi S Princess Takamatsu Symp; 1994; 24():51-62. PubMed ID: 8983063 [TBL] [Abstract][Full Text] [Related]
8. Biology of cancer invasion and metastasis. Mareel MM; Crombez R Acta Otorhinolaryngol Belg; 1992; 46(2):107-15. PubMed ID: 1605015 [TBL] [Abstract][Full Text] [Related]
9. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function. Ewing CM; Ru N; Morton RA; Robinson JC; Wheelock MJ; Johnson KR; Barrett JC; Isaacs WB Cancer Res; 1995 Nov; 55(21):4813-7. PubMed ID: 7585512 [TBL] [Abstract][Full Text] [Related]
10. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Luo J; Lubaroff DM; Hendrix MJ Cancer Res; 1999 Aug; 59(15):3552-6. PubMed ID: 10446959 [TBL] [Abstract][Full Text] [Related]
11. Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. Sommers CL; Thompson EW; Torri JA; Kemler R; Gelmann EP; Byers SW Cell Growth Differ; 1991 Aug; 2(8):365-72. PubMed ID: 1793731 [TBL] [Abstract][Full Text] [Related]
12. N-cadherin in the spotlight of cell-cell adhesion, differentiation, embryogenesis, invasion and signalling. Derycke LD; Bracke ME Int J Dev Biol; 2004; 48(5-6):463-76. PubMed ID: 15349821 [TBL] [Abstract][Full Text] [Related]
13. E-cadherin is a novel transcriptional target of the KLF6 tumor suppressor. DiFeo A; Narla G; Camacho-Vanegas O; Nishio H; Rose SL; Buller RE; Friedman SL; Walsh MJ; Martignetti JA Oncogene; 2006 Sep; 25(44):6026-31. PubMed ID: 16702959 [TBL] [Abstract][Full Text] [Related]
14. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Umbas R; Schalken JA; Aalders TW; Carter BS; Karthaus HF; Schaafsma HE; Debruyne FM; Isaacs WB Cancer Res; 1992 Sep; 52(18):5104-9. PubMed ID: 1516067 [TBL] [Abstract][Full Text] [Related]
15. Transfection of E-cadherin cDNA in human lung tumor cells reduces invasive potential of tumors. Moersig W; Horn S; Hilker M; Mayer E; Oelert H Thorac Cardiovasc Surg; 2002 Feb; 50(1):45-8. PubMed ID: 11847604 [TBL] [Abstract][Full Text] [Related]
16. Effect of p27Kip1 on the ability of invasion and metastasis of an oral cancer cell line. Supriatno ; Harada K; Kawaguchi S; Yoshida H; Sato M Oncol Rep; 2003; 10(3):527-32. PubMed ID: 12684618 [TBL] [Abstract][Full Text] [Related]
17. [When and why does cancer metastasize? An overview of current viewpoints OF the molecular mechanism of invasiveness]. Mareel M Verh K Acad Geneeskd Belg; 1994; 56(2):105-25. PubMed ID: 8048267 [TBL] [Abstract][Full Text] [Related]
18. Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells. Miyaki M; Tanaka K; Kikuchi-Yanoshita R; Muraoka M; Konishi M; Takeichi M Oncogene; 1995 Dec; 11(12):2547-52. PubMed ID: 8545111 [TBL] [Abstract][Full Text] [Related]
19. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs. Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375 [TBL] [Abstract][Full Text] [Related]
20. Enlarged cell-associated proteoglycans abolish E-cadherin functionality in invasive tumor cells. Vleminckx KL; Deman JJ; Bruyneel EA; Vandenbossche GM; Keirsebilck AA; Mareel MM; van Roy FM Cancer Res; 1994 Feb; 54(4):873-7. PubMed ID: 8313373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]